[1] |
肖建德.实用骨质疏松学[M].北京:科学出版社, 2004.
|
[2] |
Odorico JS, Kaufman DS, Thomson JA. Multilineage differentiation from human embryonic stem cell lines [J]. Stem Cells, 2001, 19(3): 193-204.
|
[3] |
Yu JY, Vodyanik MA, Smuga-Otto KA, et al. Induced pluripotent stem cell lines derived from human somatic cells [J]. Science, 2007, 318(5858): 1917-1920.
|
[4] |
Lee RH, Kim B, Choi I, et al. Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue [J]. Cell Physiol Biochem, 2004, 14(4/6): 311-324.
|
[5] |
Zuk PA. The adipose-derived stem cell: looking back and looking ahead [J]. Mol Biol Cell, 2010, 21(11): 1783-1787.
|
[6] |
Levi B, James AW, Nelson ER, et al. Studies in Adipose-Derived stromal cells: migration and participation in repair of cranial injury after systemic injection [J]. Plast Reconstr Surg, 2011, 127(3): 1130-1140.
|
[7] |
Rehman J, Traktuev D, Li J, et al. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells [J]. Circulation, 2004, 109(10): 1292-1298.
|
[8] |
González MA, Gonzalez-Rey E, Rico L, et al. Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses [J]. Gastroenterology, 2009, 136(3): 978-989.
|
[9] |
Meyerrose TE, De Ugarte DA, Hofling A, et al. In vivo distribution of human adipose-derived mesenchymal stem cells in novel xenotransplantation models [J]. Stem Cells, 2007, 25(1): 220-227.
|
[10] |
Liao XB, Li F, Wang X, et al. Distribution of murine adipose-derived mesenchymal stem cells in vivo following transplantation in developing mice [J]. Stem Cells Dev, 2008, 17(2): 303-314.
|
[11] |
Bailey AM, Lawrence MB, Shang HL, et al. Agent-Based model of therapeutic Adipose-Derived stromal cell trafficking during ischemia predicts ability to roll on P-Selectin [J]. PLoS Comput Biol, 2009, 5(2): 1000294.
|
[12] |
Yanez R, Lamana ML, Garcia-Castro JA, et al. Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease [J]. Stem Cells, 2006, 24(11): 2582-2591.
|
[13] |
Thangarajah H, Vial IN, Chang E, et al. IFATS collection: adipose stromal cells adopt a proangiogenic phenotype under the influence of hypoxia [J]. Stem Cells, 2009, 27(1): 266-274.
|
[14] |
Karp JM, Leng Teo GS. Mesenchymal stem cell homing: the devil is in the details [J]. Cell Stem Cell, 2009, 4(3): 206-216.
|
[15] |
Sackstein R. The lymphocyte homing receptors:gatekeepers of the multistep paradigm [J]. Curr Opin Hematol, 2005, 12(6): 444-450.
|
[16] |
Frenette PS, Subbarao S, Mazo IB, et al. Endothelial selectins and vascular cell adhesion molecule-1 promote hematopoietic progenitor homing to bone marrow [J]. Proc Natl AcadSci, 1998, 95(24): 14423-14428.
|
[17] |
Katayama Y, Hidalgo A, Furie BC, et al. PSGL-1 participates in E-selectinar cell adhesion molecule-1 promote hematopoietic progenitor homing to bone marrow [J]. Blood, 2003, 102(6): 2060-2067.
|
[18] |
Sipkins DA, Wei XB, Wu JW, et al. In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment [J]. Nature, 2005, 435(744): 969-973.
|
[19] |
Kannagi R. Regulatory roles of carbohydrate ligands for selectins in the homing of lymphocytes [J]. Curr Opin Struct Biol, 2002, 12(5): 599-608.
|
[20] |
Polley MJ, Phillips ML, Wayner E, et al. CD62 and endothelial cell-leukocyte adhesion molecule 1(ELAM-1) recognize the same carbohydrate ligand, sialyl-Lewis x [J]. Proc Natl Acad Sci U S A, 1991, 88(14): 6224-6228.
|
[21] |
Sackstein R. The bone marrow is akin to skin: HCELL and the biology of hematopoietic stem cell homing [J]. J Investig Dermatol Symp Proc, 2004, 9(3): 215-223.
|
[22] |
Dimitroff CJ, Lee JY, Rafii S, et al. CD44 is a major E-selectin ligand on human hematopoietic progenitor cells [J]. J Cell Biol, 2001, 153(6): 1277-1286.
|
[23] |
Cheng Z, Ou L, Zhou X, et al. Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance [J]. Mol Ther, 2008, 16(3): 571-579.
|
[24] |
Sarkar D, Spencer JA, Phillips JA, et al. Engineered cell homing [J]. Blood, 2011, 118(25): 184-191.
|
[25] |
Zhang D, Fan GC, Zhou X, et al. Over-expression of CXCR4 on mesenchymal stem cells augments myoangiogenesis in the infarcted myocardium [J]. J Mol Cell Cardiol, 2008, 44(2): 281-292.
|
[26] |
Wang J, Ye YP, Tian HT, et al. In vitro osteogenesis of human adipose-derived stem cells by coculture with human umbilical vein endothelial cells [J]. Biochem Biophys Res Commun, 2011, 412(1): 143-149.
|
[27] |
Fuhlbrigge RC, Kieffer JD, Armerding D, et al. Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells [J]. Nature, 1997, 389(6654): 978-981.
|
[28] |
Dimitroff C, Lee J, Fuhlbrigge R, et al. A distinct glycoform of CD44 is an L-selectin ligand on human hematopoietic cells [J]. Proc Natl Acad Sci U S A, 2000, 97(25): 13841-13846.
|
[29] |
Chamberlain G, Fox J, Ashton B, et al. Concise review: Mesenchymal stem cells: Their phenotype, differentiation capacity, immunological features, and potential for homing [J]. Stem Cells, 2007, 25(11): 2739-2749.
|
[30] |
Raisz LG. Pathogenesis of osteoporosis: concepts, conflicts, and prospects [J]. J Clin Invest, 2005, 115(12): 3318-3325.
|
[31] |
Rosen CJ, Bouxsein ML. Mechanisms of disease: is osteoporosis the obesity of bone? [J]. Nat Clin Pract Rheumatol, 2006, 2(1): 35-43.
|
[32] |
Sackstein R. Engineering cellular trafficking via glycosyltransferase-programmed stereosubstitution [J]. Ann N Y Acad Sci, 2012, 1253: 193-200.
|